Citigroup Inc Myriad Genetics Inc Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Citigroup Inc holds 79,495 shares of MYGN stock, worth $533,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,495

Previous 123,753 35.76%

Holding current value

$533,411

Previous $657,000 12.63%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$3.84 - $7.84 $169,950 - $346,982	-44,258 Reduced 35.76%	79,495 $574,000
Q2 2025 Aug 11, 2025	SELL	$3.84 - $8.84 $460,170 - $1.06 Million	-119,836 Reduced 49.2%	123,753 $657,000
Q1 2025 May 12, 2025	BUY	$8.87 - $14.98 $455,483 - $769,237	51,351 Added 26.71%	243,589 $2.16 Million
Q4 2024 Feb 12, 2025	BUY	$13.17 - $27.03 $975,317 - $2 Million	74,056 Added 62.66%	192,238 $2.64 Million
Q3 2024 Nov 12, 2024	BUY	$23.97 - $28.6 $843,839 - $1.01 Million	35,204 Added 42.43%	118,182 $3.23 Million

Q2 2024 Aug 12, 2024	SELL	$17.98 - $25.47 $3.31 Million - $4.69 Million	-184,128 Reduced 68.93%	82,978 $2.03 Million
Q1 2024 May 10, 2024	BUY	$17.59 - $23.59 $2.6 Million - $3.48 Million	147,679 Added 123.66%	267,106 $5.69 Million
Q4 2023 Feb 09, 2024	SELL	$13.91 - $21.32 $32,730 - $50,165	-2,353 Reduced 1.93%	119,427 $2.29 Million
Q3 2023 Nov 09, 2023	BUY	$15.99 - $23.22 $92,726 - $134,652	5,799 Added 5.0%	121,780 $1.95 Million
Q2 2023 Aug 10, 2023	SELL	$17.56 - $23.76 $1.04 Million - $1.4 Million	-59,092 Reduced 33.75%	115,981 $2.69 Million
Q1 2023 May 11, 2023	BUY	$15.26 - $23.75 $501,901 - $781,137	32,890 Added 23.13%	175,073 $4.07 Million
Q4 2022 Feb 09, 2023	SELL	$14.51 - $20.99 $802,693 - $1.16 Million	-55,320 Reduced 28.01%	142,183 $2.06 Million
Q3 2022 Nov 10, 2022	BUY	$18.21 - $27.88 $879,215 - $1.35 Million	48,282 Added 32.36%	197,503 $3.77 Million
Q2 2022 Aug 10, 2022	BUY	$16.45 - $25.88 $699,733 - $1.1 Million	42,537 Added 39.87%	149,221 $2.71 Million
Q1 2022 May 12, 2022	SELL	$22.67 - $28.01 $2.45 Million - $3.02 Million	-107,972 Reduced 50.3%	106,684 $2.69 Million
Q4 2021 Feb 10, 2022	BUY	$24.13 - $32.63 $1.98 Million - $2.68 Million	81,995 Added 61.81%	214,656 $5.93 Million
Q3 2021 Nov 10, 2021	BUY	$29.97 - $36.66 $3.98 Million - $4.86 Million	132,661 New	132,661 $4.28 Million

Others Institutions Holding MYGN

# of Institutions

238

Shares Held

92.1M

Call Options Held

86.1K

Put Options Held

18.9K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $541M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account